Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
- PMID: 32466143
- PMCID: PMC7279485
- DOI: 10.3390/ijms21103711
Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
Abstract
Genome-wide RNA sequencing has shown that only a small fraction of the human genome is transcribed into protein-coding mRNAs. While once thought to be "junk" DNA, recent findings indicate that the rest of the genome encodes many types of non-coding RNA molecules with a myriad of functions still being determined. Among the non-coding RNAs, long non-coding RNAs (lncRNA) and enhancer RNAs (eRNA) are found to be most copious. While their exact biological functions and mechanisms of action are currently unknown, technologies such as next-generation RNA sequencing (RNA-seq) and global nuclear run-on sequencing (GRO-seq) have begun deciphering their expression patterns and biological significance. In addition to their identification, it has been shown that the expression of long non-coding RNAs and enhancer RNAs can vary due to spatial, temporal, developmental, or hormonal variations. In this review, we explore newly reported information on estrogen-regulated eRNAs and lncRNAs and their associated biological functions to help outline their markedly prominent roles in estrogen-dependent signaling.
Keywords: breast cancer; eRNA; estrogen; estrogen receptor; gene-regulation; lncRNA; transcription.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells.Mol Cell Endocrinol. 2014 Jan 25;382(1):652-664. doi: 10.1016/j.mce.2013.06.021. Epub 2013 Jun 28. Mol Cell Endocrinol. 2014. PMID: 23810978 Free PMC article. Review.
-
Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.RNA Biol. 2020 Nov;17(11):1590-1602. doi: 10.1080/15476286.2020.1777769. Epub 2020 Jun 18. RNA Biol. 2020. PMID: 32506995 Free PMC article.
-
Non-coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation.Genomics Proteomics Bioinformatics. 2017 Jun;15(3):201-207. doi: 10.1016/j.gpb.2017.02.003. Epub 2017 Jun 17. Genomics Proteomics Bioinformatics. 2017. PMID: 28599852 Free PMC article. Review.
-
Interactions between short and long noncoding RNAs.FEBS Lett. 2018 Sep;592(17):2874-2883. doi: 10.1002/1873-3468.13085. Epub 2018 May 23. FEBS Lett. 2018. PMID: 29749606 Review.
-
Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice.Elife. 2024 Apr 15;13:RP91438. doi: 10.7554/eLife.91438. Elife. 2024. PMID: 38619504 Free PMC article.
Cited by
-
An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer.J Immunol Res. 2022 Jun 26;2022:9912732. doi: 10.1155/2022/9912732. eCollection 2022. J Immunol Res. 2022. PMID: 35795530 Free PMC article.
-
Roles of enhancer RNAs in sex hormone-dependent cancers.J Cancer Res Clin Oncol. 2022 Feb;148(2):293-307. doi: 10.1007/s00432-021-03886-y. Epub 2022 Jan 22. J Cancer Res Clin Oncol. 2022. PMID: 35064362 Review.
-
Identification of Prognostic Factors Related to Super Enhancer-Regulated ceRNA Network in Metastatic Lung Adenocarcinoma.Int J Gen Med. 2021 Oct 1;14:6261-6275. doi: 10.2147/IJGM.S332317. eCollection 2021. Int J Gen Med. 2021. PMID: 34629892 Free PMC article.
-
Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.Int J Mol Sci. 2022 Mar 16;23(6):3189. doi: 10.3390/ijms23063189. Int J Mol Sci. 2022. PMID: 35328609 Free PMC article. Review.
-
A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer.Front Genet. 2021 Jun 29;12:676845. doi: 10.3389/fgene.2021.676845. eCollection 2021. Front Genet. 2021. PMID: 34267780 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources